Artikel ; Online: A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted.
Cytokine & growth factor reviews
2020 Band 58, Seite(n) 49–50
Abstract: Previous studies of SARS-CoV-2 viral infection suggest that both the humoral and cytotoxic arms of the immune system are weak in patients with severe COVID-19 disease when compared to mild disease. A cytokine storm is also induced in severe disease. IL- ... ...
Abstract | Previous studies of SARS-CoV-2 viral infection suggest that both the humoral and cytotoxic arms of the immune system are weak in patients with severe COVID-19 disease when compared to mild disease. A cytokine storm is also induced in severe disease. IL-15 has been shown to support the cytotoxic arm of the immune response. IL-21 has been shown to support both the cytotoxic and humoral arms of the immune response. In addition, in some settings, Il-21 has been shown to actually decrease IL-6 and TNF-alpha production, reducing the inflammatory proteins involved in the cytokine storm. Furthermore, in other settings, the combination of IL-15 and IL-21 has been shown to be more effective than either interleukin alone in promoting an effective immune response. Therefore, a clinical trial that examines the use of the combination of IL-15 and IL-21 for COVID-19 patients is warranted. |
---|---|
Mesh-Begriff(e) | COVID-19/complications ; COVID-19/drug therapy ; COVID-19/immunology ; Clinical Trials as Topic ; Cytokine Release Syndrome/etiology ; Cytokine Release Syndrome/prevention & control ; Drug Therapy, Combination ; Humans ; Interleukin-15/administration & dosage ; Interleukins/administration & dosage ; Research Design ; SARS-CoV-2/immunology ; SARS-CoV-2/pathogenicity |
Chemische Substanzen | Interleukin-15 ; Interleukins ; interleukin-21 (MKM3CA6LT1) |
Schlagwörter | covid19 |
Sprache | Englisch |
Erscheinungsdatum | 2020-10-23 |
Erscheinungsland | England |
Dokumenttyp | Journal Article |
ZDB-ID | 1330534-7 |
ISSN | 1879-0305 ; 1359-6101 |
ISSN (online) | 1879-0305 |
ISSN | 1359-6101 |
DOI | 10.1016/j.cytogfr.2020.10.005 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 2653: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.